These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24827481)

  • 1. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Miura K; Tanaka A; Yamamoto T; Adachi M; Takikawa H
    Intern Med; 2014; 53(10):1037-42. PubMed ID: 24827481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
    Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
    Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
    Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Ratelle M; Perreault S; Villeneuve JP; Tremblay L
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
    Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
    J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
    Dam G; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
    Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
    J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
    Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
    Xu HB; Wang HD; Li CH; Ye S; Dong MS; Xia QJ; Zhang AQ; Pan K; Ge XL; Dong JH
    Genet Mol Res; 2015 Jul; 14(3):7490-501. PubMed ID: 26214428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.
    Zhang M; Liu W; Xu X; Chen T; Qi JY
    Curr Med Sci; 2022 Aug; 42(4):673-680. PubMed ID: 35870102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].
    Wang X; Wang BM; Jiang K; Zhang J; Fang WL; Wang T; Li XY
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):629-32. PubMed ID: 19954052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
    Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
    Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
    Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between proton pump inhibitor use and spontaneous bacterial peritonitis.
    Campbell MS; Obstein K; Reddy KR; Yang YX
    Dig Dis Sci; 2008 Feb; 53(2):394-8. PubMed ID: 17616817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
    Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
    Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
    De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
    World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.
    Hung TH; Tseng CW; Lee HF; Tsai CC; Tsai CC
    Ann Hepatol; 2018 Oct; 17(6):933-939. PubMed ID: 30600287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.